Elamipretide for Barth Syndrome Survives FDA Advisory Vote Panelists acknowledge difficulty generating stronger data in ultra-rare disease Oct 11, 2024
Metabolic Accelerator Shows Promise for Weight Loss Side of Obesity-HFpEF Equation Benefit in symptoms, functional outcomes remains to be seen for HU6 Oct 02, 2024
Mavacamten Shows Promise in Heart Failure With Normal to Supranormal EF Cardiac myosin inhibitor linked to improvements in biomarkers in small study Sep 30, 2024
Case Strengthens for Cardiac Myosin Inhibitor in SEQUOIA-HCM Vast majority of trial participants responded to aficamten Sep 30, 2024
Does Finerenone's Efficacy Diminish if Initiated Late in Heart Failure? Benefit of the nonsteroidal MRA otherwise consistent across FINEARTS-HF Sep 29, 2024
Reconsider When a Prophylactic ICD Is Needed in Nonischemic Dilated Cardiomyopathy Meta-analysis holds LGE higher than LVEF in identifying high-risk NIDCM Sep 20, 2024
Are Regulators the Root of the Problem of Serious Device Recalls? Study lays out common gaps in evidence both before and after approval Sep 16, 2024
Oral Anticoagulation and TAVR Together: A Recipe for Trouble Continued OAC failed to meet noninferiority in POPular PAUSE TAVI Sep 03, 2024
Nonsteroidal MRA Improves Outcomes in HFpEF, HFmrEF Randomized trial shows benefits beyond heart failure with low ejection fraction, but not survival Sep 01, 2024
Stenting, TAVR Make Sense Packaged Together for Some Patients NOTION-3 trial informs care for those with severe AS and stable CAD Sep 01, 2024
Another Trial Sides With MitraClip for Functional Mitral Regurgitation RESHAPE-HF2 has provocative implications for a wider pool of TEER candidates Aug 31, 2024
TriClip's 'Soft' Benefits Affirmed in Severe Tricuspid Regurgitation Randomized trial "highly encouraging" for making patients feel and function better Aug 31, 2024
Pause or Keep RAS Inhibitors Before Surgery? Take Your Pick. Either choice is "acceptable" based on randomized study Aug 31, 2024
Amyloidosis Drug Improves Outcomes, Survival RNA silencer impresses with results in transthyretin amyloidosis cardiomyopathy Aug 30, 2024
Bleeding Better Controlled When Protamine Is Part of TAVR Wrap-Up Routine ACE-PROTAVI trial tested upfront vs selective use of heparin reversal agent Aug 14, 2024
D.C. Hospital Gets a Wake-Up Call to Chagas Disease Report is part of larger efforts to increase awareness of neglected disease Jul 17, 2024
This U.S. President Was Dying, but His Doctors Zipped Their Lips Eight decades after FDR's decline and death, do White House physicians owe truth to the public? Jul 16, 2024
Diuretics for Ambulatory HF Patients With Volume Overload: Winners & Losers Three regimens compared head-to-head among abundant choices Jul 10, 2024
More Than 1 in 4 Seniors Have Asymptomatic Valve Disease Most cases were mild, and age was a predictor of disease Jun 27, 2024
Cardiac Shockwave Device Passes Hurdle in Ischemic Cardiomyopathy Question of clinical benefit beyond LVEF improvement will require larger trials Jun 21, 2024
Established TAVR Platforms Evolving for Lifetime Management New additions to Sapien, Evolut, Navitor lines aim to ensure coronary access Jun 10, 2024
New Tricuspid Interventions Launched into 'Broken' System Having the technology reach the right patients is a major challenge in the real world Jun 08, 2024
Can Mitral Valve Innovators Dig Themselves Out of a Rut? Current transcatheter mitral valve replacement devices a poor match for clinical need Jun 06, 2024
Phrenic Nerve Stimulation Shows Benefits in Central Sleep Apnea With Heart Failure Use of the nerve stimulator tied to a fivefold higher chance of better clinical outcomes Jun 06, 2024
Most Heart Disease Deaths Still Occur in Cold Weather, but Heat Is a Growing Problem Rising mortality burden from high ambient temperatures around the world Jun 03, 2024
Mortality Signal Emerges 2 Years After Valve-in-Valve TAVR for Failed SAVR Alternative to redo surgery associated with several-fold increase in deaths, HF hospitalization May 22, 2024
Analysis: Pulsed Field Afib Ablation Superior to Thermal Methods Also, what real-world data are showing about new workflow patterns and PFA use in heart failure May 21, 2024
Early CRT Benefits HF With Moderately Reduced Ejection Fraction Trial suggests a possible disease modifying benefit May 20, 2024
ShortCut Leaflet Splitter for TAVR Helps Keep Coronaries Unblocked Pivotal study supports safety, effectiveness of TAVR adjunct device against coronary obstruction May 17, 2024
Indian Myval Enters TAVR Horse Race With Good Early Performance Valve characterized by availability of intermediate sizes among other design features May 16, 2024
Bicuspid Anatomy: Wrench Thrown in TAVR for Younger, Low-Risk Patients? Controversial findings of low-risk trial allowing bicuspid patients May 15, 2024
Joined Cath Procedures Turn the Table on SAVR-CABG Small trial favors percutaneous approach to concomitant aortic stenosis and coronary disease May 14, 2024
Novel Cardiac Myosin Inhibitor Improves Exercise Capacity in HCM Drug appears on par for efficacy, possibly safer than first drug approved in the class May 13, 2024
Hypertrophic Cardiomyopathy Guidelines Add Drug Class, Endorse More Exercise Also, several new recommendations in update address younger patients May 08, 2024
QT-Prolonging Meds Commonly Doled Out to Dialysis Patients Most scripts originated from clinicians other than nephrologists Apr 30, 2024
Is Industry Influence Driving LVAD Use by Cardiologists? Clinical treatment decisions should be based on the best available evidence Apr 26, 2024
Too Ill for Typical Transplants, Woman Gets a Pig Kidney and Heart Pump Instead Surgery marks sixth human xenotransplant performed at NYU Langone Health Apr 24, 2024
Does Ejection Fraction Make or Break Afib Ablation in Heart Failure Patients? Survival benefit does not extend to HFpEF group, meta-analysis suggests Apr 24, 2024
FDA Announces Recall of Heart Pumps Linked to Deaths and Injuries Recall comes years after issues were first raised Apr 21, 2024
Cardiac Events Common in Older, Hospitalized RSV Patients New RSV vaccines could reduce risk, researchers said Apr 15, 2024
